Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
Introduced First Reading Assembly Referred to AFI
Summary
The bill mandates that all New Jersey health insurance contracts—including hospital, medical, HMO, individual, group, and small‑employer plans—must pay for buprenorphine or buprenorphine/naloxone when prescribed for pain. These plans cannot require step‑therapy or fail‑first protocols before covering the medication. The requirement applies to contracts issued or renewed after the law’s effective date.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when A 4550 changes status, plus AI-powered summaries and stage predictions.
Sign up free